OKA Direct Ltd has been acquired by Investindustrial
The private shareholders of OKA Direct Ltd have sold the company to Investindustrial for an undisclosed consideration.
Founded in 1999, OKA is renowned for creating interior designed homes featuring curated collections of British designed furniture and home accessories. The company has a strong direct-to-consumer offering, with a well-established online platform supported by a retail portfolio of 14 strategically placed showrooms, a successful interior design service, a strong mail order catalogue offering and a complementary trade division. At the time of sale, the shareholders included funds managed by FPE Capital, which acquired a majority stake in the company in 2007.
Investindustrial is a leading European group of independently managed investment, holding and advisory companies with US$8 billion of raised fund capital and has previously invested in well-known brands such as Aston Martin, Ducati and B&B Italia. The acquisition of OKA is part of Investindustrial’s selective investments in high-growth companies in the small and lower mid-market, building on its prior expertise in luxury brands and homewares.
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more